Digest Network Come funziona
Network
/
Società
Ge
Non verificato

GeneDx

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteSanità

74 comunicati stampa

Guarda tutti i comunicati
11/03/2026
Industria
Salute
Sanità
Biotecnologia
Medicina - Varie
Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing
Fonte
GeneDx
Emittente
Business Wire
1.00
0
10/03/2026
Industria
Biotecnologia
Sanità
Salute
Farmaceutica
Attrezzature medico-sanitarie
Politica Interna
Medicina - Varie
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
Fonte
GeneDx
Emittente
Business Wire
1.00
0
09/03/2026
Eventi
Industria
Information Technology
Tecnica
Farmaceutica
Sanità
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Scienza
Salute
GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership
Fonte
GeneDx
Emittente
Business Wire
1.00
0
25/02/2026
Web e Social Network
Fiere
Eventi
Biotecnologia
Farmaceutica
Salute
GeneDx to Participate in Upcoming Investor Conferences
Fonte
GeneDx
Emittente
Business Wire
1.00
0
23/02/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Sanità
Salute
Tecnica
INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
Fonte
GeneDx
Emittente
Business Wire
1.00
0
23/02/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Sanità
Salute
Tecnica
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
Fonte
GeneDx
Emittente
Business Wire
1.00
0
11/02/2026
TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health
Fonte
GeneDx
Emittente
Business Wire
1.00
0
03/02/2026
Biotecnologia
Sanità
Salute
Farmaceutica
Attrezzature medico-sanitarie
Politica Interna
Medicina - Varie
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026
Fonte
GeneDx
Emittente
Business Wire
1.00
0
12/01/2026
Industria
Attrezzature medico-sanitarie
Salute
Sanità
Biotecnologia
Farmaceutica
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
Fonte
GeneDx
Emittente
Business Wire
1.00
0
08/01/2026
Attrezzature medico-sanitarie
Sanità
Biotecnologia
Medicina - Varie
Politica Interna
Farmaceutica
Salute
Industria
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
Fonte
GeneDx
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0